MAC-话题@MedSci

#MAC#

655篇内容 | 2605人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1996121, encodeId=c3c71996121e2, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据, objectType=article, longId=124941, objectId=5a5b12494193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5b12494193, replyNumber=0, likeNumber=64, createdTime=2018-07-23, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5b12494193, moduleTitle=EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a5b12494193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995991, encodeId=b58c1995991c1, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？, objectType=article, longId=100531, objectId=077010053178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077010053178, replyNumber=0, likeNumber=92, createdTime=2017-10-01, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077010053178, moduleTitle=CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=077010053178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996078, encodeId=1be919960e820, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacoepidemiol Drug Saf：患过敏疾病的儿童使用H1-抗组胺药安全吗？, objectType=article, longId=118573, objectId=89291185e355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89291185e355, replyNumber=0, likeNumber=57, createdTime=2017-12-09, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89291185e355, moduleTitle=Pharmacoepidemiol Drug Saf：患过敏疾病的儿童使用H1-抗组胺药安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89291185e355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996020, encodeId=e1da19960208b, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Aliment Pharmacol Ther：维多珠单抗治疗炎症性肠病是否安全, objectType=article, longId=107040, objectId=045610e040bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=045610e040bc, replyNumber=0, likeNumber=60, createdTime=2017-12-15, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=045610e040bc, moduleTitle=Aliment Pharmacol Ther：维多珠单抗治疗炎症性肠病是否安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=045610e040bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996097, encodeId=eeb0199609e07, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacoepidem Dr S:罗格列酮的临床证据和药品监管变化对降糖治疗处方模式的影响, objectType=article, longId=121659, objectId=20bd121659dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20bd121659dc, replyNumber=0, likeNumber=77, createdTime=2018-01-10, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20bd121659dc, moduleTitle=Pharmacoepidem Dr S:罗格列酮的临床证据和药品监管变化对降糖治疗处方模式的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20bd121659dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996010, encodeId=bbec1996010ed, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Mol Cell：癌症新药Smac，结合特定抑制剂，抗癌效果倍增！, objectType=article, longId=103486, objectId=1cc3103486d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cc3103486d6, replyNumber=0, likeNumber=154, createdTime=2017-07-28, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cc3103486d6, moduleTitle=Mol Cell：癌症新药Smac，结合特定抑制剂，抗癌效果倍增！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cc3103486d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996016, encodeId=3c94199601605, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Ann Pharmacother：二肽基肽酶-4抑制剂是否应为出血风险增加“背锅”？, objectType=article, longId=104950, objectId=ef3210495099, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef3210495099, replyNumber=0, likeNumber=88, createdTime=2018-06-12, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef3210495099, moduleTitle=Ann Pharmacother：二肽基肽酶-4抑制剂是否应为出血风险增加“背锅”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef3210495099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996015, encodeId=2063199601517, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Ann Pharmacother：基于指南证据评估ICU超说明书用药特征, objectType=article, longId=104444, objectId=d6e8104444e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e8104444e6, replyNumber=0, likeNumber=0, createdTime=2018-01-06, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e8104444e6, moduleTitle=Ann Pharmacother：基于指南证据评估ICU超说明书用药特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e8104444e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996070, encodeId=691519960e006, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacoepidemiol Drug Saf：妊娠期抗抑郁药会增加哪些新生儿不良结局风险？, objectType=article, longId=117740, objectId=9c5d11e740b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c5d11e740b2, replyNumber=0, likeNumber=76, createdTime=2018-01-12, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c5d11e740b2, moduleTitle=Pharmacoepidemiol Drug Saf：妊娠期抗抑郁药会增加哪些新生儿不良结局风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c5d11e740b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995965, encodeId=f81819959656e, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Aliment Pharmacol Ther：巢式病例对照研究揭露克罗恩氏病患者阿达木单抗剂量降低的数据, objectType=article, longId=94962, objectId=35079496207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35079496207, replyNumber=0, likeNumber=56, createdTime=2017-09-26, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35079496207, moduleTitle=Aliment Pharmacol Ther：巢式病例对照研究揭露克罗恩氏病患者阿达木单抗剂量降低的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35079496207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996036, encodeId=c7901996036d5, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Ethnopharmacol：五味子提取物能降低环磷酰胺导致的大鼠肝脏、肾脏和脑部毒性, objectType=article, longId=110459, objectId=17251104592f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17251104592f, replyNumber=0, likeNumber=61, createdTime=2017-10-03, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17251104592f, moduleTitle=J Ethnopharmacol：五味子提取物能降低环磷酰胺导致的大鼠肝脏、肾脏和脑部毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17251104592f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996049, encodeId=646a1996049d6, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Ann Pharmacother：NVAF患者使用DOAC治疗影响剂量合理性的是什么？, objectType=article, longId=113647, objectId=cd1611364e27, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd1611364e27, replyNumber=0, likeNumber=59, createdTime=2018-01-02, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd1611364e27, moduleTitle=Ann Pharmacother：NVAF患者使用DOAC治疗影响剂量合理性的是什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd1611364e27)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996062, encodeId=bdfe199606262, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Psychopharmacol：适量饮酒可提高第二语言的发音和学习能力！, objectType=article, longId=116813, objectId=9aa211681369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aa211681369, replyNumber=0, likeNumber=70, createdTime=2018-07-27, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aa211681369, moduleTitle=J Psychopharmacol：适量饮酒可提高第二语言的发音和学习能力！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aa211681369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996137, encodeId=f156199613eee, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int Immunopharmacol：LOX-1参与了种植体周围炎的发病机制, objectType=article, longId=129255, objectId=bf0c1292557d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf0c1292557d, replyNumber=0, likeNumber=67, createdTime=2018-03-17, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf0c1292557d, moduleTitle=Int Immunopharmacol：LOX-1参与了种植体周围炎的发病机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf0c1292557d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996085, encodeId=edbd19960851b, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur J Clin Pharmacol：益生菌联合三联疗法治疗儿童幽门螺杆菌感染, objectType=article, longId=119555, objectId=c10f11955573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c10f11955573, replyNumber=0, likeNumber=155, createdTime=2017-12-18, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c10f11955573, moduleTitle=Eur J Clin Pharmacol：益生菌联合三联疗法治疗儿童幽门螺杆菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c10f11955573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996037, encodeId=afaf199603e0d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Ocul Pharmacol Ther：原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响！, objectType=article, longId=110474, objectId=039b1104e4a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039b1104e4a0, replyNumber=0, likeNumber=68, createdTime=2018-01-21, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039b1104e4a0, moduleTitle=J Ocul Pharmacol Ther：原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039b1104e4a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996027, encodeId=5399199602e83, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Br J Clin Pharmacol：哪些因素决定外用氨甲环酸治疗全膝关节置换术后出血的疗效？, objectType=article, longId=108250, objectId=4f611082501c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f611082501c, replyNumber=0, likeNumber=125, createdTime=2017-09-22, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f611082501c, moduleTitle=Br J Clin Pharmacol：哪些因素决定外用氨甲环酸治疗全膝关节置换术后出血的疗效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f611082501c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995997, encodeId=30b7199599e12, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=CLIN PHARMACOKINET：类风湿关节炎患者中Sarilumab和辛伐他汀药物相互作用, objectType=article, longId=100591, objectId=6072100591b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6072100591b0, replyNumber=0, likeNumber=73, createdTime=2017-07-30, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6072100591b0, moduleTitle=CLIN PHARMACOKINET：类风湿关节炎患者中Sarilumab和辛伐他汀药物相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6072100591b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996012, encodeId=360e1996012ac, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacotherapy：治疗良性前列腺增生的药物会增加抑郁症发病风险吗？, objectType=article, longId=103977, objectId=31ca1039e7ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ca1039e7ec, replyNumber=0, likeNumber=82, createdTime=2017-12-24, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ca1039e7ec, moduleTitle=Pharmacotherapy：治疗良性前列腺增生的药物会增加抑郁症发病风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ca1039e7ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int Immunopharmacol：商陆皂苷甲或能治疗神经炎性疾病, objectType=article, longId=111209, objectId=cd751112098f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd751112098f, replyNumber=0, likeNumber=152, createdTime=2018-07-19, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd751112098f, moduleTitle=Int Immunopharmacol：商陆皂苷甲或能治疗神经炎性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd751112098f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MAC

2020-05-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据

2018-07-23

yb6560 (审核中...)

前往app查看评论内容

#MAC#

CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？

2017-10-01

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacoepidemiol Drug Saf：患过敏疾病的儿童使用H1-抗组胺药安全吗？

2017-12-09

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Aliment Pharmacol Ther：维多珠单抗治疗炎症性肠病是否安全

2017-12-15

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacoepidem Dr S:罗格列酮的临床证据和药品监管变化对降糖治疗处方模式的影响

2018-01-10

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Mol Cell：癌症新药Smac，结合特定抑制剂，抗癌效果倍增！

2017-07-28

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Ann Pharmacother：二肽基肽酶-4抑制剂是否应为出血风险增加“背锅”？

2018-06-12

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Ann Pharmacother：基于指南证据评估ICU超说明书用药特征

2018-01-06

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacoepidemiol Drug Saf：妊娠期抗抑郁药会增加哪些新生儿不良结局风险？

2018-01-12

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Aliment Pharmacol Ther：巢式病例对照研究揭露克罗恩氏病患者阿达木单抗剂量降低的数据

2017-09-26

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ethnopharmacol：五味子提取物能降低环磷酰胺导致的大鼠肝脏、肾脏和脑部毒性

2017-10-03

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Ann Pharmacother：NVAF患者使用DOAC治疗影响剂量合理性的是什么？

2018-01-02

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Psychopharmacol：适量饮酒可提高第二语言的发音和学习能力！

2018-07-27

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int Immunopharmacol：LOX-1参与了种植体周围炎的发病机制

2018-03-17

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur J Clin Pharmacol：益生菌联合三联疗法治疗儿童幽门螺杆菌感染

2017-12-18

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ocul Pharmacol Ther：原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响！

2018-01-21

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Br J Clin Pharmacol：哪些因素决定外用氨甲环酸治疗全膝关节置换术后出血的疗效？

2017-09-22

yb6560 (审核中...)

前往app查看评论内容

#MAC#

CLIN PHARMACOKINET：类风湿关节炎患者中Sarilumab和辛伐他汀药物相互作用

2017-07-30

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacotherapy：治疗良性前列腺增生的药物会增加抑郁症发病风险吗？

2017-12-24

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int Immunopharmacol：商陆皂苷甲或能治疗神经炎性疾病

2018-07-19

科室
- - 订阅+
  - 更多科室
工具
服务